|
|
| November 15, 2016: Dr. C. Michael Gibson Presents: AEGIS-I: The Safety and Tolerability of CSL112, A Reconstituted, Infusible, Human ApoA-I |
Dr. C. Michael Gibson Presents: AEGIS-I: The Safety and Tolerability of CSL112, A
Reconstituted, Infusible, Human ApoA-I, After Acute Myocardial Infarction - The ApoA-I
Event Reduction In Ischemic Syndromes I (AEGIS-I) Trial
TBD
[ Download video ] |
|
No comments have been submitted
|